Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Re Max Lataillade, the Gates Foundation, and what

Message Board Public Reply | Private Reply | Keep | Replies (3)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155273
(Total Views: 974)
Posted On: 12/09/2024 8:38:02 AM
Posted By: KenChowder
Re Max Lataillade, the Gates Foundation, and what some seem to think (or pretend to think) might be a conflict of interest:

1) People have worked and do work for the Gates Foundation and private companies at the same time. Example, GSK.

2) While they've been working for both Gates and GSK, the Gates Foundation has funded GSK clinical trials and research. It has, for example, funded GSK's research into vaccines/treatments for malaria, tuberculosis, and HIV.

So never mind conflict of interest.

I noticed the other day that the Gates Foundation has purchased an interest in Novo Nordisk, a Danish company which is by Danish standards quite large, known for diabetes and weight-loss (see: Ozempic).

ChatGpt says: :Novo Nordisk has become a key player in global health and is also involved in initiatives supported by the Gates Foundation, such as the Pandemic Antiviral Discovery (PAD) program, which focuses on developing accessible antiviral medicines for future pandemics."

Cytodyn has a drug that should be trialed for many indications. If you were Bill Gates and had an abiding interest in indications that mattered most to underserved populations, you might consider buying a stake in a company that could go many different directions with its platform drug. You could put $60 million into the company, get a controlling interest, dictate its areas of keenest interest, and, oh yes, make a profit. I've heard Bill Gates knows how to make a profit.

This is not a supposition or a guess but a pipe dream. (Jake has counseled me to mention this. Respert has counseled me to have a nice Pinot and chill. Evil has counseled me to watch old movies and learn. I follow everyone's advice.)


(13)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us